Abstract
We demonstrate, by means of on-tissue mass spectrometry of tissue sections, that the drug probenecid can penetrate the blood–brain barrier. This method holds general promise for the detection and distribution of small molecule drugs within organ and tissue compartments.
References
Beckmann N, Laurent D, Tigani B, Panizzutti R, Rudin M (2004) Magnetic resonance imaging in drug discovery: lessons from disease areas. Drug Discov Today 9:35–42
Bhaskaracharya A, Dao-Ung P, Jalilian I, Spildrejorde M, Skarratt KK, Fuller SJ, Sluyter R, Stokes L (2014) Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS One 9:e93058
Caprioli RM, Farmer TB, Gile J (1997) Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 69:4751–4760
Colín-González AL, Santamaría A (2013) Probenecid: an emerging tool for neuroprotection. CNS Neurol Disord Drug Targets 12:1050–1065
Dahl G, Qiu F, Wang J (2013) The bizarre pharmacology of the ATP release channel pannexin1. Neuropharmacology 75:583–593
Eijkel GB, Kükrer Kaletaş B, Wiel IM van der, Kros JM, Luider TM, Heeren RMA (2009) Correlating MALDI and SIMS imaging mass spectrometric datasets of biological tissue surfaces. Surf Interface Anal 41:675–685
Gode D, Volmer DA (2013) Lipid imaging by mass spectrometry—a review. Analyst 138:1289–1315
Koch SE, Gao X, Haar L, Jiang M, Lasko VM, Robbins N, Cai W, Brokamp C, Varma P, Tranter M, Liu Y, Ren X, Lorenz JN, Wang H-S, Jones WK, Rubinstein J (2012) Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. J Mol Cell Cardiol 53:134–144
Matthews PM, Rabiner EA, Passchier J, Gunn RN (2012) Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol 73:175–186
McDonnell LA, Heeren RMA (2007) Imaging mass spectrometry. Mass Spectrom Rev 26:606–643
Orellana JA, Montero TD, Bernhardi R von (2013) Astrocytes inhibit nitric oxide-dependent Ca2+ dynamics in activated microglia: involvement of ATP released via pannexin 1 channels. Glia 61:2023–2037
Qi Y, O’Connor PB (2014) Data processing in Fourier transform ion cyclotron resonance mass spectrometry. Mass Spectrom Rev 33:333–352
Schwamborn K, Caprioli RM (2010) Molecular imaging by mass spectrometry—looking beyond classical histology. Nat Rev Cancer 10:639–646
Seeley EH, Caprioli RM (2011) MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 29:136–143
Wang L, Hong H, Zhang D (2012) Applications of quantitative whole-body autoradiography (QWBA) in drug discovery and development. In: Zhang D, Surapaneni S (eds) ADME-enabling technologies in drug design and development. Wiley, Hoboken, pp 419–434
Acknowledgments
Ms Ann Soether is gratefully acknowledged for language correction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yulin Qi and Nadine Hainz contributed equally to this work.
The authors acknowledge financial support from the DFG, which funded the FTICR-MS instrument. D.A.V. acknowledges general research support by the Alfried Krupp von Bohlen und Halbach Stiftung.
All authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Qi, Y., Hainz, N., Tschernig, T. et al. Differential distribution of probenecid as detected by on-tissue mass spectrometry. Cell Tissue Res 360, 427–429 (2015). https://doi.org/10.1007/s00441-015-2153-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-015-2153-4